Bioline Rx reported $245.1M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 45M 339M Jun/2025
Bio Path USD 3M 2M Jun/2025
Bioline Rx USD 56M 45M Jun/2025
Capricor Therapeutics USD 207M 227M Jun/2025